While spending on oncology drugs in the U.S. is anticipated to reach $125 billion by 2027, overall drug savings of...
According to the American Cancer Society, more than 18 million people in the U.S. have cancer, and many of them...
With the median cost of new oncology drugs over $260,000, it’s no wonder payers continue to look for opportunities to...
As a payer, you are challenged to keep costs low while enabling appropriate care for your members. Eviti Connect is...
NantHealth explores the impact of new biosimilar drugs for autoimmune treatment. We will discuss how payers can prepare for the...
According to a study published in The Commonweath Fund Issue Brief titled U.S. Health Care from a Global Perspective, 2022:...
Oncology innovations and cancer care treatment are complex, exceeding an estimated $200 billion in 2020. As cancer research constantly develops new...
There is a disconnect between what patients and physicians believe to be unfair treatment in the context of cancer care....
We welcome Dr. Tiffany Avery, Chief Medical Officer for NantHealth for a in-depth discussion on the multi-factor nature of healthcare....
Podcast Episode 43: Health Disparities in Oncology and Beyond with Dr. Tiffany Avery, Chief Medical Officer, NantHealth We welcome Dr....
Cancer care is costly and complex; and if you don’t have the tools needed to effectively manage your cancer spend,...
Oncology has a lot on its plate. As cancer care is welcoming a bounty of new treatments, it is absorbing...